PepGen Inc. (PEPG)
NASDAQ: PEPG
· Real-Time Price · USD
1.54
0.10 (6.94%)
At close: Jun 03, 2025, 3:59 PM
1.51
-2.27%
After-hours: Jun 03, 2025, 05:25 PM EDT
6.94% (1D)
| Bid | 1.39 |
| Market Cap | 50.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -102.16M |
| EPS (ttm) | -3.14 |
| PE Ratio (ttm) | -0.49 |
| Forward PE | -0.72 |
| Analyst | Buy |
| Ask | 1.56 |
| Volume | 207,668 |
| Avg. Volume (20D) | 316,763 |
| Open | 1.50 |
| Previous Close | 1.44 |
| Day's Range | 1.35 - 1.54 |
| 52-Week Range | 0.88 - 19.30 |
| Beta | 1.39 |
About PEPG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PEPG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PEPG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+67.15%
PepGen shares are trading higher after the company...
Unlock content with
Pro Subscription
4 months ago
-21.74%
PepGen shares are trading lower after HC Wainwright & Co. cut its price target on the stock from $26 to $16.
2 months ago · businesswire.com
PepGen to Present at the 24th Annual Needham Virtual Healthcare ConferenceBOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of se...
2 months ago · accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPGNEW YORK, NY / ACCESS Newswire / April 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to con...
